David Paydarfar

David Paydarfar, M.D. serves as Professor and inaugural Chair of Neurology at Dell Medical School, The University of Texas at Austin, while directing the Mulva Clinic for the Neurosciences. Previously, he held leadership roles at University of Massachusetts Medical School and Harvard-affiliated Wyss Institute, establishing a career bridging clinical neurology and biomedical engineering to transform neurological care through technology innovation.

Education:

• B.S. in Physics (summa cum laude), Duke University
• M.D., University of North Carolina at Chapel Hill
• Neurology Residency, Harvard Medical School / Massachusetts General Hospital

Research Focus: Dr. Paydarfar's dual research programs pioneer predictive health monitoring through biosensors and signal-processing algorithms, while investigating neural oscillator mechanisms in apnea, epilepsy, and circadian disorders. His work integrates physiology, engineering, and data science to forecast adverse health trajectories—extending beyond reactive systems to enable preemptive interventions using digital twin technology and population-scale analytics.

Publication Trends: Recent work (2023-2025) reveals accelerating integration of multi-ancestry genomics with digital health solutions, particularly in Alzheimer's disease risk prediction and stroke transport optimization. His team consistently bridges fundamental oscillator physiology with clinical applications, increasingly leveraging digital twins for cardiovascular and neurological precision medicine while addressing health disparities through ancestry-specific analyses.

Scientific Recognition:

• Bevan Visiting Professor, University of Canterbury (2008)
• Dunaway Burnham Visiting Scholar, Dartmouth (2007, 2012)
• David A. Chad Teaching Award, UMass Medical School (2015)
• Fellow, American Neurological Association
• Member, Alpha Omega Alpha Honorary Society
• National Central University Visiting Professorship (2012)

Research Support: Continuously funded by major federal agencies including NIH and NSF, alongside the Clayton Foundation for Research, supporting translational work from basic neural oscillator studies to clinical biosensor deployment. His grants consistently emphasize engineering-informed clinical solutions with demonstrated impact on predictive health monitoring and neurological disorder management.

Collaborative Infrastructure: Leads the Physiological Laboratories at Dell Med, fostering interdisciplinary teams of neurologists, engineers, and data scientists through the Mulva Clinic for the Neurosciences. His collaborations extend to Harvard's Wyss Institute and national consortia focused on digital health validation and neurodegenerative disease genomics.